Simultaneous Determination of Norfloxacin and Tinidazole in Tablets by Reverse Phase High Performance Liquid Chromatography (RP - HPLC).

Abstract

A new simple, precise, rapid and selective HPLC-RP method has been developed for the simultaneous determination of Norfloxacin and Tinidazole in formulations, using 0.2 % Triethylamine (TEA) in water : Acetonitrile (80:20,v/v) and pH adjusted to 2.6 to 2.8 with Phosphoric acid, as a mobile phase, and C₁₈ SHODEX column (5 micron, 25 cm × 3.9 mm, ID) as stationary phase. Detection was carried out using a UV detector at 311 nm Linearity range and percentage recoveries for Norfloxacin and Tinidazole were 20 - 200 μg/mL and 30 - 300 μg/mL, 999.91 % and 99.94 % respectively.     

Determination of Metoclopramide in Serum by HPLC Assay and Its Application to Pharmacokinetic Study in Rat

Abstract

A simple, sensitive, and reproducible HPLC method has been developed for the determination of metoclopramide employing reversed phase high performance liquid chromatography with UV detection at 270 nm. The separation was performed on a Novapak C₁₈, 4 μm (3.9 × 150 mm) column. Acetonitrile (18%) in 0.02 M ammonium acetate containing 0.1% triethylamine was used as the mobile phase and the run time was 7 min. Tramadol was used as the internal standard. The mean retention times of metoclopramide and tramadol were 3.4 and 4.6 min, respectively. Linear response (r > 0.997) was observed over the range of 0.025–5 μg/ml of metoclopramide. There was no significant difference (p < 0.05) between inter- and intra-day studies for metoclopramide. The mean relative standard deviations (RSD%) of the results of within-day precision and accuracy of the drug were < 10%. The applicability of the assay was demonstrated in measuring metoclopramide pharmacokinetics in rats. The elimination half-life was 2.09 ± 0.39 h with an apparent clearance of 2.45 ± 0.70 (L/h)/kg in rat.     

A Gradient Reversed Phase High Performance Liquid Chromatography Method for Simultaneous Determination of Hydrochlorothiazide (HCT) and Losartan Potassium (LOS) from Tablets.

ABSTRACT

A new, precise, accurate gradient reverse phase high performance liquid chromatography (RP-HPLC) method has been developed for the simultaneous determination of Hydrochlorothiazide (HCT) and Losartan potassium (LOS) in tablets. The stationary phase was Microbondapak C18 column (10 μ, 300 mm × 3.9 mm ID). A gradient elution with an aqueous methanolic mobile phase (pH=3) was employed for the separation. Detection was carried out at 270 nm using UV detector. The flow rate was 1.0 ml/min and retention times were 7.89 minutes and 15.15 minutes for HCT and LOS, respectively. The linearity was obtained in the concentration range of 0.5 - 200 μg/ml for HCT and 2 - 800 μg/ml for LOS. Mean percentage recoveries were 100.29% and 99.16% for HCT and LOS, respectively.     

Quantitative analysis of Pentalgin N tablets by gradient and isocratic high-performance liquid chromatography

Two procedures were proposed for the quantitative analysis of the drug Pentalgin N with the use of HPLC in gradient and isocratic modes. Analgin (dipyrone), caffeine, naproxen, phenobarbital, codeine, an analgin degradation product, and sodium sulfite (added to the test solution to stabilize analgin) were separated on a column (150 × 3.9 mm) packed with Nova-Pak C18 (4.0 μm) with elution with a 0.00625 M KH₂ PO₄ solution with an acetonitrile concentration gradient from 10 to 60 vol % in 10 min or on a column (150 × 3.9 mm) packed with Nova-Pak CN HP (4.0 μm) with elution with a 0.0110 M KH₂ PO₄ solution (pH 5.8) containing 5 vol % acetonitrile. The wavelength of the diode-array detector was 212 nm. Model solutions containing all of the active principles and additives of the tablets were analyzed, and the performance characteristics of both procedures were calculated. Both procedures afford reliable analytical results; however, the isocratic version is technically simpler and more preferable for product control in commercial production.     

The Rapid Determination of Neopterine in Human Urine by Isocratic High-Performance Liquid Chromatography

Abstract

An isocratic high-performance liquid chromatography method is described for the determination of Neopterine eliminated in human urine, using a μ-Bondapak C₁₈ column (300 × 3.9 mm I.D.) and a strongly polar phosphate buffer (pH 6.2) for elution. This analysis requires only 15 minutes and allows very good reproduc-tibility of retention times. This method is well-suited for automation and routine clinical laboratory in order to quantify human urinary Neopterine in healthy subjects and in subjects with malignant disorders.     

Parabens determination with a hybrid FIA/HPLC system with ultra-short monolithic column

The combination of an ultra-short C18 monolithic column (5 mm long) with a flow injection analysis (FIA) scheme results in a versatile and efficient system that has been used for the chromatographic determination of four preservatives — methylparaben (MP), ethylparaben (EP), propylparaben (PP) and butylparaben (BP). The separation is carried out by using two carriers, A and B, consisting of a mixture of ACN: water in different proportions. The described procedure is able to separate the analytes in only 150 s. The applicable concentration range, detection limit and the relative standard deviation were the following: for MP from 1.6 × 10^-5 to 1.1 × 10^-3 M; 4.8 × 10^-4 M; 0.65%; for EP between 3.7 × 10^-5 and 2.0 × 10^-3 M; 1.2 × 10^-5 M; 1.2%; for PP between 3.9 × 10^-5 and 2.0 × 10^-3 M; 1.2 × 10^-5 M; 1.2%; and for BT between 6.0 × 10^-5 and 2.0 × 10^-3 M; 1.8 × 10^-5 M; 1.8%. The method was applied and validated satisfactorily for the determination of these parabens in commercial cosmetics samples, comparing the results with those obtained by HPLC reference method.     

Sensitive Determination of Piritramide in Human Plasma by High-Performance Liquid Chromatography

Abstract

A selective and sensitive method for the determination of piritramide in human plasma is described. After addition of 50 μl of 2 M ammonia and 20 μl of aqueous promethazine solution (100 ng/10 μ1) as an internal standard, 1 ml of plasma was extracted with 5 ml of toluene (extraction efficiency: 93.9 × 2.6%; mean × S. D.; n = 5). HPLC was performed with a phenyl hypersil NC-04 column, particle size 5 μm, 250 × 4 mm I. D.; mobile phase: 8 parts of acetonitrile and 2 parts of 10 mM potassium phosphate buffer (pH 3. 3). The flow rate was set to 2 ml/min and the column temperature was 22°C. The assay was linear in a concentration range of 3.75 ? 3000 ng/ml (r = 0.999), with a lower limit of detection of 3 ng/ml. The precision was determined using spiked plasma samples (15 ng/ml; 300 ng/ml), with coefficients of variation of 6.1 and 5.9% (intraday; n = 5) and 6.5 and 0.2% (interday; n = 3). In the range of 5.6 ? 1500 ng/ml, the accuracy of the assay was 2.82%. The method was used for the determination of piritramide plasma concentrations in patients receiving intra- or postoperative analgesia.     

Quantitative determination of 8-hydroxy-2′-deoxyguanosine as a biomarker of oxidative stress in thalassemic patients using HPLC with an electrochemical detector

A simple and robust HPLC method with electrochemical detection was developed for the quantitative determination of 8-hydroxy-2′-deoxyguanosine (8-OHdG), a DNA damage product excreted in urine. Sample cleanup was carried out using solid-phase extraction (SPE) prior to chromatographic separation. 8-OHdG was well separated on an Eclipse XDB®-C18 column (150 × 4.6 mm i.d., 5 μm) with an Eclipse XDB®-C18 guard column (12 × 4.6 mm i.d., 5 μm). Two mobile phases containing methanol and 10 mM sodium formate (pH 4.5) at a ratio of 10: 90 and 50: 50 v/v, respectively, were used. The retention time of 8-OHdG was 9.8 ± 0.5 min. The recovery of 8-OHdG was found to be 97.2 ± 3.3% (n = 6). Intraday and interday precisions of the method were 4.0 ± 2.9% (n = 6) and 6.6 ± 1.7% (n = 6), respectively. The detection limit was 5 ng/mL. Preliminary investigation showed that the mean value of 8-OHdG, normalized with the amount of creatinine in the sample, from the thalassemic group was significantly higher than that from healthy subjects (211 ± 214 ng/mg creatinine vs. 31.4 ± 32.2 ng/mg creatinine, respectively), indicating oxidative stress.     

Separation of cannabinoids on three different mixed‐mode columns containing carbon/nanodiamond/amine‐polymer superficially porous particles

Three mixed‐mode high‐performance liquid chromatography columns packed with superficially porous carbon/nanodiamond/amine‐polymer particles were used to separate mixtures of cannabinoids. Columns evaluated included: (i) reversed phase (C₁₈), weak anion exchange, 4.6 × 33 mm, 3.6 μm, and 4.6 × 100 mm, 3.6 μm, (ii) reversed phase, strong anion exchange (quaternary amine), 4.6×33 mm, 3.6 μm, and (iii) hydrophilic interaction liquid chromatography, 4.6 × 150 mm, 3.6 μm. Different selectivities were achieved under various mobile phase and stationary phase conditions. Efficiencies and peak capacities were as high as 54 000 N/m and 56, respectively. The reversed phase mixed‐mode column (C₁₈) retained tetrahydrocannabinolic acid strongly under acidic conditions and weakly under basic conditions. Tetrahydrocannabinolic acid was retained strongly on the reversed phase, strong anion exchange mixed‐mode column under basic polar organic mobile phase conditions. The hydrophilic interaction liquid chromatography column retained polar cannabinoids better than the (more) neutral ones under basic conditions. A longer reversed phase (C₁₈) mixed‐mode column (4.6 × 100 mm) showed better resolution for analytes (and a contaminant) than a shorter column. Fast separations were achieved in less than 5 min and sometimes 2 min. A real world sample (bubble hash extract) was also analyzed by gradient elution.     

Versatile chromatographic method for catechin determination in development of topical formulations containing natural extracts

Catechin is found in several natural sources, as Eugenia dysenterica and Syzygium cumini extracts. Its antioxidant and UV‐protective properties suggest a potential use in cosmetic and dermatological formulations. A simple analytical method capable of giving support to experiments performed along the development of topical formulations containing this natural substance (i.e. drug assay, skin permeation and stability studies), however, is still needed. Thus, this work aimed to develop and validate a selective HPLC method for catechin determination during the development of topical formulations. Separation was achieved using an RP‐C₁₈ column (300 × 3.9 mm; 10 μm), with a mobile phase of methanol–phosphoric acid 0.01 m (15: 85, v/v), a flow rate of 0.8 mL/min, temperature set at 40°C and UV detection at 230 nm. The method was linear in a range from 0.5 to 10.0 μg/mL (r = 0.9998), precise with an overall variation coefficient of 5.5% and accurate with catechin recovery from the skin layers >85%. Additionally, the method was sensitive (limit of detection, 0.109 μg/mL; limit of quantification, 0.342 μg/mL) and selective against plant extracts, skin matrices and formulation interferents, as well as catechin degradation products. It was also robust regarding both methodology parameters and analytical stability.     

An HPLC‐UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfan

Dimethylacetamide (DMA) is a solvent used in the preparation of intravenous busulfan, an alkylating agent used in blood or marrow transplantation. DMA may contribute to hepatic toxicity, so it is important to monitor its clearance. The aim of this study was to develop an HPLC‐UV assay for measurement of DMA in human plasma. After precipitation of plasma proteins with acetonitrile followed by dilution (1:4) with water, the extract was injected onto the HPLC and detected at 195 nm. Separation was performed using a Cogent‐HPS 5 μm C₁₈ column (250 × 4.6 mm) preceded by a Brownlee 7 μm RP₁₈, pre‐column (1.5 cm × 3.2 mm). The mobile phase was 25 mm sodium phosphate buffer (pH 3), containing 2.5% (v /v) acetonitrile and 0.0005% (v /v) sodium‐octyl‐sulfonate. Using a flow rate of 1 mL/min, the retention times of DMA and the internal standard (IS), 2‐chloroacetamide, were 9.5 and 3.5 min, respectively. Peak area ratio (DMA:IS) was a linear function of concentration from 1 to 1000 μg/mL. There was excellent intraday precision (<5% for 5–700 μg/mL DMA), accuracy (<3% deviation from the true concentration) and recovery (74–98%). The limits of detection and quantification were 1 and 5 μg/mL, respectively. In eight children who received intravenous busulfan, DMA concentrations ranged from 110 to 438 μg/mL.     

Pre-column chelation liquid chromatographic separation and determination of trace V,Cu, Co,Pd, Fe and Ni

Conditions for the separation by reversed-phase liquid chromatography (LC) of V(V), Cu(II), Co(III), Pd(II), Fe(III) and Ni(II) chelates with 2-(5-bromopyridylazo)-5-diethylaminophenol (5-Br-PADAP) were studied. Six species of metal chelates were separated successfully with methanol-acetonitrile-water (72:12:16, v/v/v) containing 0.13 M NaCl and 0.29 mM cetyltrimethylammonium bromide (pH 5.0) as the mobile phase on a Nucleosil C₁₈ (5 μm) column (250 × 4 mm i.d.).The conditions of the determination of these metal chelates are discussed. A simple and rapid method for the determination of trace amounts of V(V), Cu(II), Co(III), Pd(II) and Ni(II) simultaneously by reversed-phase LC has been developed. The detection limits are 5 × 10^?12, 1 × 10^?10, 3 × 10^?11, 5.3 × 10^?9 and 2 × 10^?10 g, respectively. The method is applied to the determination of these metals in natural waters and mineral samples.     

Observation of nicotinic acid in nicorandil samples and simultaneous determination of nicorandil and its three degradation products in raw drug and tablet form by high performance liquid chromatography

Nicotinic acid (NA) as a degradation product of nicorandil (NIC) was identified and quantified by HPLC-DAD and GC / MS. In the present paper a rapid, sensitive, precise and specific HPLC-DAD method was developed for the simultaneous determination of NIC, NA and two known degradation products, nitrate (NI) and de-nitrated nicorandil [N-(2-hydroxyethyl) nicotinamide] (HEN) in raw drug and tablet form. The present method was performed on an ODS C₁₈ column (150 × 4.6 mm, 5 μm) using detection at 204 nm and employing nicotinamide (NT) as internal standard. The procedure was validated by evaluating linearity, accuracy and recovery and applied to monitor the increased level of NI, HEN and NA as a function of NIC storage time at room temperature.     

Optimization of chromatography to overcome matrix effect for reliable estimation of four small molecular drugs from biological fluids using LC–MS/MS

The article describes a systematic study to overcome the matrix effect during chromatographic analysis of gemfibrozil, rivastigmine, telmisartan and tacrolimus from biological fluids using LC–ESI–MS/MS. All four methods were thoroughly developed by the appropriate choice of analytical column, elution mode and pH of mobile phase for improved chromatography and overall method performance. Matrix effect was assessed by post-column analyte infusion, slope of calibration line approach and post-extraction spiking. The best chromatographic conditions established were: Acquity BEH C₁₈ (50 × 2.1 mm, 1.7 μm) column with 5.0 mm ammonium acetate, pH 6.0–methanol as the mobile phase under gradient program for gemfibrozil; Luna CN (50 × 2.0 mm, 3 μm) column with a mobile phase consisting of acetonitrile–10 mm ammonium acetate, pH 7.0 (90:10, v/v) for rivastigmine; Inertsustain C₁₈ (100 × 2.0 mm, 5 μm) column using methanol–2.0 mm ammonium formate, pH 5.5 (80: 20, v/v) as the mobile phase for isocratic elution of telmisartan; and Acquity BEH C₁₈ (50 × 2.1 mm, 1.7 μm) with methanol–10 mm ammonium acetate, pH 6.0 (95:5, v/v) as mobile phase for tacrolimus. The methods were thoroughly validated as per European Medicines Agency and US Food and Drug Administration guidance and were successfully applied for pharmacokinetic studies in healthy subjects.     

Quantitative analysis of Pentalgin tablets by gradient and isocratic high-performance liquid chromatography

The retention of paracetamol, propyphenazone, caffeine, phenobarbital, and codeine phosphate, which are the components of the new medicine Pentalgin, was studied by reversed-phase high-performance liquid chromatography on a column (150 × 3.9 mm) filled with the Symmetry C18 sorbent (5.0 μm) in the gradient elution mode and on a column (150 × 3.9 mm) filled with the Nova-Pak CN HP sorbent (4.0 μm) as a function of the profile and composition of the gradient and as a function of the concentrations of acetonitrile and KH₂PO₄ and the pH of the mobile phase, respectively, with detection at 212 nm. The optimum composition of the mobile phase was selected. The time of separation was 16 and 11 min for the gradient and isocratic elution modes, respectively. The procedures were used for the analysis of a preproduction sample of the tablets. The procedures provide accurate and reproducible results of analysis; however, the isocratic version is preferable for mass production control as a technically simpler technique.     

A Chemometrical Approach to Optimization and Validation of an HPLC Assay for Rizatriptan and its Impurities in Tablets

Abstract

An isocratic reversed‐phase high‐performance liquid chromatographic method was developed and validated for the analysis of a novel antimigraine drug, rizatriptan benzoate, in a dosage form along with its two impurities, L‐749.019 and L‐783.540. The method used a C₁₈ XTerra? (150×3.9 mm), 5 µm column. The mobile phase consisted of a mixture of methanol, TEA (1%) and 10 mM KH₂PO₄ (5:9.5:85.5 v/v) at a flow rate of 1.2 ml min^?1 (pH of the water phase was adjusted to 5.5 with 85% orthophosphoric acid). Column temperature was 20°C and the detection was performed at 225 nm. The central composite design technique and the response surface method were used in the robustness test considerations. The method was applied satisfactorily to the analysis of commercial rizatriptan formulation.     

Determination of vitamin K<Subscript>1</Subscript> in blood serum by high-performance liquid chromatography

A method is proposed for the determination of vitamin K₁ concentration in blood serum using HPLC on a Gemini C18 (250 mm × 4.6 mm ID, 5 μm) column and elution with a methanol–acetonitrile–dichloromethane (45 : 50 : 5, v/v) mobile phase at a flow rate of 1 mL/min and detection at 248 nm. The limit of detection for the vitamin is 0.5 ng/mL and relative error is 19%. The volume of sample in the column is 100 μL. The method has been applied to the evaluation of vitamin K₁ deficit in a human body in medical practice.     

Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra‐performance liquid chromatography tandem mass spectrometry

Choline fenofibrate is the choline salt of fenofibric acid, which releases free fenofibric acid in the gastrointestinal tract. To estimate the absolute oral bioavailability of fenofibric acid and choline fenofibrate, a novel and sensitive UPLC–MS/MS method with liquid–liquid extraction procedure was developed for the determination of fenofibric acid in rat plasma. The separation was achieved on a Phenomenex Kinetex C₁₈ column (50 × 2.1 mm, 2.6 μm) containing 2 mm ammonium acetate–methanol with a gradient elution program. Validations of this method including specificity, sensitivity (limit of quantification, 5 ng/mL), linearity (0.005–10 μg/mL), accuracy (within ±4.3%), precision (intra‐ and inter‐day coefficient of variation <11.3%), recovery (94.9–105.2% for fenofibric acid), matrix effect, stability and dilution, were all within acceptable limits. This method successfully supported the determination of fenofibric acid and choline fenofibrate. The absolute oral bioavailability was 93.4% for choline fenofibrate and 40.0% for fenofibric acid. These results suggested that choline fenofibrate and fenofibric acid had a better in vivo pharmacokinetic behavior than that of fenofibrate. The two new orally administrated pharmaceuticals, fenofibric acid and choline fenofibrate, can be developed as alternatives to fenofibrate.     

Simultaneous High Performance Liquid Chromatographic Determination of Amitriptyline Hydrochloride and Perphenazine in Tablet Formulations

Abstract

A rapid, precise, and accurate high performance liquid chromatographic procedure is presented for the simultaneous determination of amitriptyline hydrochloride and perphenazine in two component tablet formulations. The related compounds of amitriptyline hydrochloride were separated, making the determination specific for amitriptyline hydrochloride and perphenazine. The method was used for the assay and content uniformity for three commercial products. The mobile phase was 0.02 M ammonium acetate in aceto-nitrile: methanol: water (45:15:40) solution and the pH was adjusted to 5.0 by acetic acid. The column was a supelcosil (5 μm) LC-8-DB (250 mm × 4.6 mm i. d). The method was tested for linearity, recovery, and specificity.     

Comparison of Reverse-Phase High-Performance Liquid Chromatographic Methods for Precolumn-Derivatized Amino Acids

Abstract

A comparison was made among five precolumn derivatization techniques for amino acid analysis using reverse-phase high-performance liquid chromatography (HPLC). All chromatographic analyses were conducted using the same instrumentation and a C₁₈ Ultrasphere ODS column (5 μm, 250 × 4.6 mm). The precolumn derivatization methodologies studied included the formation of OPA (o-phthaldialdehyde), DANSYL (dimethylaminonaphthalenesulphonyl), DABSYL (dimethylaminoazobenzenesulphonyl), PTH (phenylthiohydantoin), and PTC (phenylthiocarbamyl) derivatives. The derivatization procedures were evaluated for simplicity, time required, and derivative stability. HPLC analyses of the amino acid derivatives were compared in terms of resolution, sensitivity, reproducibility, and time of analysis.